These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32706857)

  • 1. Donor Cytomegalovirus Transmission Patterns in Solid Organ Transplant Recipients With Primary Infection.
    Hasing ME; Pang XL; Mabilangan C; Preiksaitis JK
    J Infect Dis; 2021 Mar; 223(5):827-837. PubMed ID: 32706857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assessment of donor-to-recipient transmission patterns of human cytomegalovirus by analysis of viral genomic variants.
    Manuel O; Pang XL; Humar A; Kumar D; Doucette K; Preiksaitis JK
    J Infect Dis; 2009 Jun; 199(11):1621-8. PubMed ID: 19385736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion-transmitted and community-acquired cytomegalovirus infection in seronegative solid organ transplant recipients receiving seronegative donor organs.
    Mabilangan C; Burton C; Nahirniak S; O'Brien S; Preiksaitis J
    Am J Transplant; 2020 Dec; 20(12):3509-3519. PubMed ID: 32428296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus transmission in mismatched solid organ transplant recipients: Are factors other than anti-viral prophylaxis at play?
    Hernandez C; Mabilangan C; Burton C; Doucette K; Preiksaitis J
    Am J Transplant; 2021 Dec; 21(12):3958-3970. PubMed ID: 34174153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer risk associated with cytomegalovirus infection among solid organ transplant recipients in the United States.
    Geris JM; Spector LG; Pfeiffer RM; Limaye AP; Yu KJ; Engels EA
    Cancer; 2022 Nov; 128(22):3985-3994. PubMed ID: 36126024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor Graft Cytomegalovirus Serostatus and the Risk of Arterial and Venous Thrombotic Events in Seronegative Recipients After Non-Thoracic Solid Organ Transplantation.
    Belga S; MacDonald C; Chiang D; Kabbani D; Shojai S; Abraldes JG; Cervera C
    Clin Infect Dis; 2021 Mar; 72(5):845-852. PubMed ID: 32025704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and Outcome of Ganciclovir-Resistant Cytomegalovirus Infection After Solid Organ Transplantation: A Single Transplant Center Experience in Thailand.
    Bruminhent J; Rotjanapan P; Watcharananan SP
    Transplant Proc; 2017 Jun; 49(5):1048-1052. PubMed ID: 28583524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing Proportion of High-risk Cytomegalovirus Donor-positive/Recipient-negative Serostatus in Solid Organ Transplant Recipients.
    Imlay H; Wagener MM; Vutien P; Perkins J; Singh N; Limaye AP
    Transplantation; 2023 Apr; 107(4):988-993. PubMed ID: 36173456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of glycoproteins B and H genotypes to predict the development of Cytomegalovirus disease in solid organ transplant recipients.
    Barrado L; Prieto C; Hernando S; Folgueira L
    J Clin Virol; 2018 Dec; 109():50-56. PubMed ID: 30500488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: a single-center retrospective cohort study.
    Young PG; Rubin J; Angarone M; Flaherty J; Penugonda S; Stosor V; Ison MG
    Transpl Infect Dis; 2016 Jun; 18(3):390-5. PubMed ID: 27037651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMV infection and management among pediatric solid organ transplant recipients.
    Downes KJ; Sharova A; Boge CLK; Vader D; Mitrou M; Hayes M; Galetaki DM; Gianchetti L; Vella LA; Li Y
    Pediatr Transplant; 2022 May; 26(3):e14220. PubMed ID: 34994041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Area-Level Social Deprivation and Cytomegalovirus Seropositivity at the Time of Solid Organ Transplant.
    Abidi MZ; Lopez R; Arrigain S; Weinberg A; Kaplan B; McAdams-DeMarco M; Schold JD; Erlandson KM
    JAMA Netw Open; 2024 Oct; 7(10):e2437878. PubMed ID: 39374014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of blood and tissue diagnostics for gastrointestinal cytomegalovirus disease in solid organ transplant recipients.
    Fisher CE; Alexander J; Bhattacharya R; Rakita RM; Kirby KA; Boeckh M; Limaye AP
    Transpl Infect Dis; 2016 Jun; 18(3):372-80. PubMed ID: 27004439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A risk-stratified approach to cytomegalovirus prevention in pediatric solid organ transplant recipients.
    Suresh S; Lee BE; Robinson JL; Akinwumi MS; Preiksaitis JK
    Pediatr Transplant; 2016 Nov; 20(7):970-980. PubMed ID: 27565955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coinfection rates and clinical outcome data for cytomegalovirus and Epstein-Barr virus in post-transplant patients: A systematic review of the literature.
    Anderson-Smits C; Baker ER; Hirji I
    Transpl Infect Dis; 2020 Dec; 22(6):e13396. PubMed ID: 32603496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New developments in the management of cytomegalovirus infection after solid organ transplantation.
    Eid AJ; Razonable RR
    Drugs; 2010 May; 70(8):965-81. PubMed ID: 20481654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Going beyond serology for stratifying the risk of CMV infection in transplant recipients.
    Navarro D; Fernández-Ruiz M; Aguado JM; Sandonís V; Pérez-Romero P
    Rev Med Virol; 2019 Jan; 29(1):e2017. PubMed ID: 30358016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infection in Solid Organ Transplant Recipients.
    Fisher CE; Knudsen JL; Lease ED; Jerome KR; Rakita RM; Boeckh M; Limaye AP
    Clin Infect Dis; 2017 Jul; 65(1):57-63. PubMed ID: 28369203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease.
    Manuel O; Asberg A; Pang X; Rollag H; Emery VC; Preiksaitis JK; Kumar D; Pescovitz MD; Bignamini AA; Hartmann A; Jardine AG; Humar A
    Clin Infect Dis; 2009 Oct; 49(8):1160-6. PubMed ID: 19751151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.
    Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska A; Gozdowska J; Ciszek M; Serwanska-Swietek M; Domagala P; Miszewska-Szyszkowska D; Sitarek E; Jozwik A; Kwiatkowski A; Durlik M
    BMC Infect Dis; 2018 Apr; 18(1):179. PubMed ID: 29661141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.